[DPHARMA] YoY TTM Result on 31-Dec-2012 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
25-Feb-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
31-Dec-2012 [#4]
Profit Trend
QoQ- -1.26%
YoY- -2.59%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Revenue 271,040 176,961 162,404 135,311 138,132 131,437 123,765 13.94%
PBT 49,765 46,490 40,177 35,297 34,729 35,410 38,215 4.49%
Tax -10,980 -8,009 -6,690 -9,282 -8,023 -6,741 -7,981 5.45%
NP 38,785 38,481 33,487 26,015 26,706 28,669 30,234 4.23%
-
NP to SH 38,785 35,679 33,487 26,015 26,706 28,669 30,234 4.23%
-
Tax Rate 22.06% 17.23% 16.65% 26.30% 23.10% 19.04% 20.88% -
Total Cost 232,255 138,480 128,917 109,296 111,426 102,768 93,531 16.36%
-
Net Worth 270,323 192,951 181,818 169,359 163,776 156,744 142,996 11.19%
Dividend
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Div 5,682 25,682 24,289 19,431 24,987 6,402 16,743 -16.47%
Div Payout % 14.65% 71.98% 72.53% 74.69% 93.56% 22.33% 55.38% -
Equity
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Net Worth 270,323 192,951 181,818 169,359 163,776 156,744 142,996 11.19%
NOSH 278,959 138,813 138,792 138,819 138,793 138,711 138,831 12.32%
Ratio Analysis
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
NP Margin 14.31% 21.75% 20.62% 19.23% 19.33% 21.81% 24.43% -
ROE 14.35% 18.49% 18.42% 15.36% 16.31% 18.29% 21.14% -
Per Share
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
RPS 162.43 127.48 117.01 97.47 99.52 94.76 89.15 10.51%
EPS 23.24 25.70 24.13 18.74 19.24 20.67 21.78 1.08%
DPS 3.41 18.50 17.50 14.00 18.00 4.61 12.06 -18.97%
NAPS 1.62 1.39 1.31 1.22 1.18 1.13 1.03 7.83%
Adjusted Per Share Value based on latest NOSH - 138,819
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
RPS 28.18 18.40 16.88 14.07 14.36 13.66 12.87 13.94%
EPS 4.03 3.71 3.48 2.70 2.78 2.98 3.14 4.24%
DPS 0.59 2.67 2.53 2.02 2.60 0.67 1.74 -16.48%
NAPS 0.281 0.2006 0.189 0.1761 0.1703 0.1629 0.1487 11.18%
Price Multiplier on Financial Quarter End Date
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Date 31/12/15 31/12/14 31/12/13 31/12/12 30/12/11 30/12/10 31/12/09 -
Price 2.62 2.50 2.58 2.13 2.02 2.39 2.40 -
P/RPS 1.61 1.96 2.20 2.19 2.03 2.52 2.69 -8.19%
P/EPS 11.27 9.73 10.69 11.37 10.50 11.56 11.02 0.37%
EY 8.87 10.28 9.35 8.80 9.53 8.65 9.07 -0.37%
DY 1.30 7.40 6.78 6.57 8.91 1.93 5.03 -20.18%
P/NAPS 1.62 1.80 1.97 1.75 1.71 2.12 2.33 -5.87%
Price Multiplier on Announcement Date
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Date 23/02/16 24/02/15 26/02/14 25/02/13 22/02/12 23/02/11 23/02/10 -
Price 2.61 2.92 2.60 2.17 2.12 2.45 2.33 -
P/RPS 1.61 2.29 2.22 2.23 2.13 2.59 2.61 -7.73%
P/EPS 11.23 11.36 10.78 11.58 11.02 11.85 10.70 0.80%
EY 8.91 8.80 9.28 8.64 9.08 8.44 9.35 -0.79%
DY 1.30 6.34 6.73 6.45 8.49 1.88 5.18 -20.57%
P/NAPS 1.61 2.10 1.98 1.78 1.80 2.17 2.26 -5.49%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment